Stay updated on AVT04 in Chronic Plaque Psoriasis Clinical Trial

Sign up to get notified when there's something new on the AVT04 in Chronic Plaque Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AVT04 in Chronic Plaque Psoriasis Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer shows a site revision update from v3.7.2 to v3.8.0, while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-31T19:19:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A notice announces NIH’s website transition and says the term “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-24T20:32:35.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T22:07:34.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T22:03:18.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The page continues to show a 403 Forbidden error, with no visible change between the screenshots.
    Difference
    0.2%
    Check dated 2026-10-03T21:38:45.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating access is blocked and the study information is not retrievable from this page.
    Difference
    18%
    Check dated 2026-09-19T21:54:19.000Z thumbnail image

Stay in the know with updates to AVT04 in Chronic Plaque Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AVT04 in Chronic Plaque Psoriasis Clinical Trial page.